INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46m ago
House PTR6m ago
SEC 13F6m ago
Robinhood Chain6m ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.58B / 21S · 3 late79 trades$24.55M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

65,929 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUY
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
BJ
Boattini JenniferSR VP Legal/General Counsel
JBHTHUNT J B TRANSPORT SERVICES INC
Tax withholding
F$43K
196 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
BJ
Boattini JenniferSR VP Legal/General Counsel
JBHTHUNT J B TRANSPORT SERVICES INC
Option exercise
M—
528 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
BJ
Boattini JenniferSR VP Legal/General Counsel
JBHTHUNT J B TRANSPORT SERVICES INC
Tax withholding
F$40K
180 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
BJ
Boattini JenniferSR VP Legal/General Counsel
JBHTHUNT J B TRANSPORT SERVICES INC
Option exercise
M—
427 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
SG
Salvia Investment GmbH10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
160.9K sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
WK
Wright Russell KeithVP and CAO
CNPCENTERPOINT ENERGY INC
Tax withholding
F$9,464
223 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
GJ
Gahan Patrick JosephDirector
QMLSQumulusAI, Inc.
Option exercise
M—
182 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
VH
van Houte HansChief Financial Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,859 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
WM
Weakley MonicaDirector
AGNTAGNT, Inc.
Grant or award
A$31.41
9 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
16.4K sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
EL
Evans Terry LChief Commercial Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
168 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
BJ
Boattini JenniferSR VP Legal/General Counsel
JBHTHUNT J B TRANSPORT SERVICES INC
Option exercise
M—
434 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
156 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
GJ
Gahan Patrick JosephDirector
QMLSQumulusAI, Inc.
Option exercise
M$601
182 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
94.0K sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
15.8K sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
KC
Krosnowski Scott CarrollChief Financial Officer
QMLSQumulusAI, Inc.
Option exercise
M$14K
4,740 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
EM
Ellerbrook Michael MPresident, UFP Construction
UFPIUFP INDUSTRIES INC
Grant or award
A$1,393
17 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
VH
van Houte HansChief Financial Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
3,573 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
VH
van Houte HansChief Financial Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
3,573 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
MF
Mottola FrankSVP, Chief Tech. Ops. Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Grant or award
A—
100.0K sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
MM
Mulhall Christopher M.VP - Chief Accounting Officer
FTVFortive Corp
Option exercise
M—
1,017 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
SP
Schwartz Barry PaulDirector
QMLSQumulusAI, Inc.
Option exercise
M$331
479 sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Grant or award
A—
758.2K sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC Form 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Grant or award
A—
379.1K sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC Form 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
147.2K sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
SG
Salvia Investment GmbH10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
3.14M sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
SA
Schultz Leigh AnnDirector
SHENSHENANDOAH TELECOMMUNICATIONS CO/VA/
Grant or award
A$667
66 sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
BJ
Boattini JenniferSR VP Legal/General Counsel
JBHTHUNT J B TRANSPORT SERVICES INC
Option exercise
M—
434 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
MM
Mulhall Christopher M.VP - Chief Accounting Officer
FTVFortive Corp
Option exercise
M$39K
1,017 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
VH
van Houte HansChief Financial Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
3,750 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
AE
Alfonso EduardoDirector
BLCOBausch & Lomb Corp
Grant or award
A$23K
1,125 sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC Form 4

Evidence

9
BJ
Boattini JenniferSR VP Legal/General Counsel
JBHTHUNT J B TRANSPORT SERVICES INC
Option exercise
M—
474 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
AS
Awsare SaleelDirector, President & CEO
LTRXLANTRONIX INC
Option exercise
M—
156.8K sh
Nov 1, 2026Nov 2, 2026
traded Nov 1, 2026
+1dSEC Form 4

Evidence

9
SG
Salvia Investment GmbH10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
1.47M sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
4,155 sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
10.4K sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
1,753 sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
DJ
DiCiollo Anthony JHead of Institutional Segment
SNEXStoneX Group Inc.
Grant or award
A—
6,604 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
KC
Krosnowski Scott CarrollChief Financial Officer
QMLSQumulusAI, Inc.
Option exercise
M—
50.7K sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

Page 85 of 1649
← PrevNext →
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 3
7 insiders$1.34M
  • SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  • SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  • BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  • SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K